StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2022, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 01 Aug 2022 09:17:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Form 8-K Cortexyme, Inc. For: Aug 01 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cortexyme%2C+Inc.+++++++++++For%3A+Aug+01/20393981.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cortexyme%2C+Inc.+++++++++++For%3A+Aug+01/20393981.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cortexyme%2C+Inc.+++++++++++For%3A+Aug+01/20393981.html Mon, 01 Aug 2022 09:17:00 -0400 CRTX Cortexyme Corporate Name Change to Quince Therapeutics to Take Effect on August 1, 2022 http://www.streetinsider.com/Press+Releases/Cortexyme+Corporate+Name+Change+to+Quince+Therapeutics+to+Take+Effect+on+August+1%2C+2022/20372145.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Cortexyme+Corporate+Name+Change+to+Quince+Therapeutics+to+Take+Effect+on+August+1%2C+2022/20372145.html for the full story. http://www.streetinsider.com/Press+Releases/Cortexyme+Corporate+Name+Change+to+Quince+Therapeutics+to+Take+Effect+on+August+1%2C+2022/20372145.html Wed, 27 Jul 2022 08:01:00 -0400 CRTX O.37557959 QNCX Cortexyme Corporate Name Change to Quince Therapeutics to Take Effect on August 1, 2022 http://www.streetinsider.com/Press+Releases/Cortexyme+Corporate+Name+Change+to+Quince+Therapeutics+to+Take+Effect+on+August+1%2C+2022/20372145.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Cortexyme+Corporate+Name+Change+to+Quince+Therapeutics+to+Take+Effect+on+August+1%2C+2022/20372145.html for the full story. http://www.streetinsider.com/Press+Releases/Cortexyme+Corporate+Name+Change+to+Quince+Therapeutics+to+Take+Effect+on+August+1%2C+2022/20372145.html Wed, 27 Jul 2022 08:01:00 -0400 CRTX O.37557959 QNCX Cortexyme Corporate Name Change to Quince Therapeutics to Take Effect on August 1, 2022 http://www.streetinsider.com/Press+Releases/Cortexyme+Corporate+Name+Change+to+Quince+Therapeutics+to+Take+Effect+on+August+1%2C+2022/20372145.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Cortexyme+Corporate+Name+Change+to+Quince+Therapeutics+to+Take+Effect+on+August+1%2C+2022/20372145.html for the full story. http://www.streetinsider.com/Press+Releases/Cortexyme+Corporate+Name+Change+to+Quince+Therapeutics+to+Take+Effect+on+August+1%2C+2022/20372145.html Wed, 27 Jul 2022 08:01:00 -0400 CRTX O.37557959 QNCX Cortexyme Corporate Name Change to Quince Therapeutics to Take Effect on August 1, 2022 http://www.streetinsider.com/Business+Wire/Cortexyme+Corporate+Name+Change+to+Quince+Therapeutics+to+Take+Effect+on+August+1%2C+2022/20372145.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Cortexyme+Corporate+Name+Change+to+Quince+Therapeutics+to+Take+Effect+on+August+1%2C+2022/20372145.html for the full story. http://www.streetinsider.com/Business+Wire/Cortexyme+Corporate+Name+Change+to+Quince+Therapeutics+to+Take+Effect+on+August+1%2C+2022/20372145.html Wed, 27 Jul 2022 08:01:00 -0400 CRTX O.37557959 QNCX Cortexyme Corporate Name Change to Quince Therapeutics to Take Effect on August 1, 2022 http://www.streetinsider.com/Business+Wire/Cortexyme+Corporate+Name+Change+to+Quince+Therapeutics+to+Take+Effect+on+August+1%2C+2022/20372145.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Cortexyme+Corporate+Name+Change+to+Quince+Therapeutics+to+Take+Effect+on+August+1%2C+2022/20372145.html for the full story. http://www.streetinsider.com/Business+Wire/Cortexyme+Corporate+Name+Change+to+Quince+Therapeutics+to+Take+Effect+on+August+1%2C+2022/20372145.html Wed, 27 Jul 2022 08:01:00 -0400 CRTX O.37557959 QNCX Cortexyme Corporate Name Change to Quince Therapeutics to Take Effect on August 1, 2022 http://www.streetinsider.com/Business+Wire/Cortexyme+Corporate+Name+Change+to+Quince+Therapeutics+to+Take+Effect+on+August+1%2C+2022/20372145.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Cortexyme+Corporate+Name+Change+to+Quince+Therapeutics+to+Take+Effect+on+August+1%2C+2022/20372145.html for the full story. http://www.streetinsider.com/Business+Wire/Cortexyme+Corporate+Name+Change+to+Quince+Therapeutics+to+Take+Effect+on+August+1%2C+2022/20372145.html Wed, 27 Jul 2022 08:01:00 -0400 CRTX O.37557959 QNCX Cortexyme Successfully Completes Phase 1 Single and Multiple Ascending Dose Clinical Trial of COR588 http://www.streetinsider.com/Press+Releases/Cortexyme+Successfully+Completes+Phase+1+Single+and+Multiple+Ascending+Dose+Clinical+Trial+of+COR588/20372003.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Cortexyme+Successfully+Completes+Phase+1+Single+and+Multiple+Ascending+Dose+Clinical+Trial+of+COR588/20372003.html for the full story. http://www.streetinsider.com/Press+Releases/Cortexyme+Successfully+Completes+Phase+1+Single+and+Multiple+Ascending+Dose+Clinical+Trial+of+COR588/20372003.html Wed, 27 Jul 2022 08:00:00 -0400 CRTX O.37557959 Cortexyme Successfully Completes Phase 1 Single and Multiple Ascending Dose Clinical Trial of COR588 http://www.streetinsider.com/Press+Releases/Cortexyme+Successfully+Completes+Phase+1+Single+and+Multiple+Ascending+Dose+Clinical+Trial+of+COR588/20372003.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Cortexyme+Successfully+Completes+Phase+1+Single+and+Multiple+Ascending+Dose+Clinical+Trial+of+COR588/20372003.html for the full story. http://www.streetinsider.com/Press+Releases/Cortexyme+Successfully+Completes+Phase+1+Single+and+Multiple+Ascending+Dose+Clinical+Trial+of+COR588/20372003.html Wed, 27 Jul 2022 08:00:00 -0400 CRTX O.37557959 Cortexyme Successfully Completes Phase 1 Single and Multiple Ascending Dose Clinical Trial of COR588 http://www.streetinsider.com/Business+Wire/Cortexyme+Successfully+Completes+Phase+1+Single+and+Multiple+Ascending+Dose+Clinical+Trial+of+COR588/20372003.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Cortexyme+Successfully+Completes+Phase+1+Single+and+Multiple+Ascending+Dose+Clinical+Trial+of+COR588/20372003.html for the full story. http://www.streetinsider.com/Business+Wire/Cortexyme+Successfully+Completes+Phase+1+Single+and+Multiple+Ascending+Dose+Clinical+Trial+of+COR588/20372003.html Wed, 27 Jul 2022 08:00:00 -0400 CRTX O.37557959 Cortexyme Successfully Completes Phase 1 Single and Multiple Ascending Dose Clinical Trial of COR588 http://www.streetinsider.com/Business+Wire/Cortexyme+Successfully+Completes+Phase+1+Single+and+Multiple+Ascending+Dose+Clinical+Trial+of+COR588/20372003.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Cortexyme+Successfully+Completes+Phase+1+Single+and+Multiple+Ascending+Dose+Clinical+Trial+of+COR588/20372003.html for the full story. http://www.streetinsider.com/Business+Wire/Cortexyme+Successfully+Completes+Phase+1+Single+and+Multiple+Ascending+Dose+Clinical+Trial+of+COR588/20372003.html Wed, 27 Jul 2022 08:00:00 -0400 CRTX O.37557959 Cortexyme (CRTX) Announces Resignation of EVP of Research and Development http://www.streetinsider.com/Corporate+News/Cortexyme+%28CRTX%29+Announces+Resignation+of+EVP+of+Research+and+Development/20358206.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Cortexyme+%28CRTX%29+Announces+Resignation+of+EVP+of+Research+and+Development/20358206.html for the full story. http://www.streetinsider.com/Corporate+News/Cortexyme+%28CRTX%29+Announces+Resignation+of+EVP+of+Research+and+Development/20358206.html Fri, 22 Jul 2022 16:30:13 -0400 CRTX Cortexyme (CRTX) Announces Resignation of EVP of Research and Development http://www.streetinsider.com/Management+Changes/Cortexyme+%28CRTX%29+Announces+Resignation+of+EVP+of+Research+and+Development/20358206.html Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Cortexyme+%28CRTX%29+Announces+Resignation+of+EVP+of+Research+and+Development/20358206.html for the full story. http://www.streetinsider.com/Management+Changes/Cortexyme+%28CRTX%29+Announces+Resignation+of+EVP+of+Research+and+Development/20358206.html Fri, 22 Jul 2022 16:30:13 -0400 CRTX Form 8-K Cortexyme, Inc. For: Jul 20 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cortexyme%2C+Inc.+++++++++++For%3A+Jul+20/20358171.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cortexyme%2C+Inc.+++++++++++For%3A+Jul+20/20358171.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cortexyme%2C+Inc.+++++++++++For%3A+Jul+20/20358171.html Fri, 22 Jul 2022 16:26:00 -0400 CRTX Form SC 13G/A Cortexyme, Inc. Filed by: Capital World Investors http://www.streetinsider.com/SEC+Filings/Form++SC+13GA+++Cortexyme%2C+Inc.++++++++++++++++++++++++Filed+by%3A+Capital+World+Investors/20306557.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++SC+13GA+++Cortexyme%2C+Inc.++++++++++++++++++++++++Filed+by%3A+Capital+World+Investors/20306557.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++SC+13GA+++Cortexyme%2C+Inc.++++++++++++++++++++++++Filed+by%3A+Capital+World+Investors/20306557.html Fri, 08 Jul 2022 12:57:00 -0400 CRTX Form 4 Cortexyme, Inc. For: Jun 29 Filed by: Monohon Ted http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cortexyme%2C+Inc.+++++++++++For%3A+Jun+29++Filed+by%3A+Monohon+Ted/20285579.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cortexyme%2C+Inc.+++++++++++For%3A+Jun+29++Filed+by%3A+Monohon+Ted/20285579.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cortexyme%2C+Inc.+++++++++++For%3A+Jun+29++Filed+by%3A+Monohon+Ted/20285579.html Fri, 01 Jul 2022 17:03:00 -0400 CRTX Cortexyme Announces Preclinical Data Demonstrating Efficacy of COR803 for the Treatment of Coronavirus Infections http://www.streetinsider.com/Press+Releases/Cortexyme+Announces+Preclinical+Data+Demonstrating+Efficacy+of+COR803+for+the+Treatment+of+Coronavirus+Infections/20234581.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Cortexyme+Announces+Preclinical+Data+Demonstrating+Efficacy+of+COR803+for+the+Treatment+of+Coronavirus+Infections/20234581.html for the full story. http://www.streetinsider.com/Press+Releases/Cortexyme+Announces+Preclinical+Data+Demonstrating+Efficacy+of+COR803+for+the+Treatment+of+Coronavirus+Infections/20234581.html Tue, 21 Jun 2022 08:00:00 -0400 CRTX O.37557959 Cortexyme Announces Preclinical Data Demonstrating Efficacy of COR803 for the Treatment of Coronavirus Infections http://www.streetinsider.com/Press+Releases/Cortexyme+Announces+Preclinical+Data+Demonstrating+Efficacy+of+COR803+for+the+Treatment+of+Coronavirus+Infections/20234581.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Cortexyme+Announces+Preclinical+Data+Demonstrating+Efficacy+of+COR803+for+the+Treatment+of+Coronavirus+Infections/20234581.html for the full story. http://www.streetinsider.com/Press+Releases/Cortexyme+Announces+Preclinical+Data+Demonstrating+Efficacy+of+COR803+for+the+Treatment+of+Coronavirus+Infections/20234581.html Tue, 21 Jun 2022 08:00:00 -0400 CRTX O.37557959 Cortexyme Announces Preclinical Data Demonstrating Efficacy of COR803 for the Treatment of Coronavirus Infections http://www.streetinsider.com/Business+Wire/Cortexyme+Announces+Preclinical+Data+Demonstrating+Efficacy+of+COR803+for+the+Treatment+of+Coronavirus+Infections/20234581.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Cortexyme+Announces+Preclinical+Data+Demonstrating+Efficacy+of+COR803+for+the+Treatment+of+Coronavirus+Infections/20234581.html for the full story. http://www.streetinsider.com/Business+Wire/Cortexyme+Announces+Preclinical+Data+Demonstrating+Efficacy+of+COR803+for+the+Treatment+of+Coronavirus+Infections/20234581.html Tue, 21 Jun 2022 08:00:00 -0400 CRTX O.37557959 Cortexyme Announces Preclinical Data Demonstrating Efficacy of COR803 for the Treatment of Coronavirus Infections http://www.streetinsider.com/Business+Wire/Cortexyme+Announces+Preclinical+Data+Demonstrating+Efficacy+of+COR803+for+the+Treatment+of+Coronavirus+Infections/20234581.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Cortexyme+Announces+Preclinical+Data+Demonstrating+Efficacy+of+COR803+for+the+Treatment+of+Coronavirus+Infections/20234581.html for the full story. http://www.streetinsider.com/Business+Wire/Cortexyme+Announces+Preclinical+Data+Demonstrating+Efficacy+of+COR803+for+the+Treatment+of+Coronavirus+Infections/20234581.html Tue, 21 Jun 2022 08:00:00 -0400 CRTX O.37557959 Cortexyme Appoints June Bray to its Board of Directors http://www.streetinsider.com/Press+Releases/Cortexyme+Appoints+June+Bray+to+its+Board+of+Directors/20205145.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Cortexyme+Appoints+June+Bray+to+its+Board+of+Directors/20205145.html for the full story. http://www.streetinsider.com/Press+Releases/Cortexyme+Appoints+June+Bray+to+its+Board+of+Directors/20205145.html Mon, 13 Jun 2022 08:00:00 -0400 A.05390659 A.13640485 A.20422478 A.25855526 CRTX O.02035221 O.06071337 O.19919773 O.29774822 O.37557959 Cortexyme Appoints June Bray to its Board of Directors http://www.streetinsider.com/Press+Releases/Cortexyme+Appoints+June+Bray+to+its+Board+of+Directors/20205145.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Cortexyme+Appoints+June+Bray+to+its+Board+of+Directors/20205145.html for the full story. http://www.streetinsider.com/Press+Releases/Cortexyme+Appoints+June+Bray+to+its+Board+of+Directors/20205145.html Mon, 13 Jun 2022 08:00:00 -0400 A.05390659 A.13640485 A.20422478 A.25855526 CRTX O.02035221 O.06071337 O.19919773 O.29774822 O.37557959 Cortexyme Appoints June Bray to its Board of Directors http://www.streetinsider.com/Press+Releases/Cortexyme+Appoints+June+Bray+to+its+Board+of+Directors/20205145.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Cortexyme+Appoints+June+Bray+to+its+Board+of+Directors/20205145.html for the full story. http://www.streetinsider.com/Press+Releases/Cortexyme+Appoints+June+Bray+to+its+Board+of+Directors/20205145.html Mon, 13 Jun 2022 08:00:00 -0400 A.05390659 A.13640485 A.20422478 A.25855526 CRTX O.02035221 O.06071337 O.19919773 O.29774822 O.37557959 Cortexyme Appoints June Bray to its Board of Directors http://www.streetinsider.com/Press+Releases/Cortexyme+Appoints+June+Bray+to+its+Board+of+Directors/20205145.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Cortexyme+Appoints+June+Bray+to+its+Board+of+Directors/20205145.html for the full story. http://www.streetinsider.com/Press+Releases/Cortexyme+Appoints+June+Bray+to+its+Board+of+Directors/20205145.html Mon, 13 Jun 2022 08:00:00 -0400 A.05390659 A.13640485 A.20422478 A.25855526 CRTX O.02035221 O.06071337 O.19919773 O.29774822 O.37557959 Cortexyme Appoints June Bray to its Board of Directors http://www.streetinsider.com/Press+Releases/Cortexyme+Appoints+June+Bray+to+its+Board+of+Directors/20205145.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Cortexyme+Appoints+June+Bray+to+its+Board+of+Directors/20205145.html for the full story. http://www.streetinsider.com/Press+Releases/Cortexyme+Appoints+June+Bray+to+its+Board+of+Directors/20205145.html Mon, 13 Jun 2022 08:00:00 -0400 A.05390659 A.13640485 A.20422478 A.25855526 CRTX O.02035221 O.06071337 O.19919773 O.29774822 O.37557959